retinor pharmaceutical private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 26 bids — AKSHAT PHARMACY appeared in 12 of them.
RETINOR PHARMACEUTICAL PRIVATE LIMITED
RETINOR PHARMACEUTICAL PRIVATE LIMITED
Financial Details
Registered Office
FLAT NO. 205, PLOT NO.1-98/5A&5B JYOTHI RESIDENCY, VITTAL RAO NAGAR,NA-HYDERABAD-Telangana-500081-India
Industry Classification
Manufacturing (Metals & Chemicals, and products thereof)
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
152
Contract Value
₹13.64 Cr
L1 Bids
20
Recent Win Rate
20.0%
Performance Analytics
Retinor Pharmaceutical Private Limited: Business Analysis and Strategic Recommendations
Retinor Pharmaceutical Private Limited demonstrates a strong engagement in India's public procurement, participating in 152 government tenders. With a 13.2% win rate and increasing contract values, this analysis provides insights into their bidding performance, competitive positioning, and strategic opportunities for growth.
Executive Summary
This business analysis examines the government tender performance of Retinor Pharmaceutical Private Limited, focusing on key performance indicators (KPIs), financial metrics, competitive landscape, and strategic recommendations. Key highlights include a 13.2% overall win rate, a total contract value of ₹13.64 Crore, and specialized engagement with the Department of Military Affairs. Despite a concerning financial health score of 46.3/100, the company shows moderate positive growth and opportunities for strategic improvement.
Financial Performance of Retinor Pharmaceutical
Retinor Pharmaceutical's financial performance in government tenders reveals both strengths and areas for improvement. The following provides a detailed breakdown of key financial metrics:
- Total Contract Value: Retinor Pharmaceutical has secured contracts with a total value of ₹13,63,66,568.0 across 152 tenders.
- Average Bid Amount: The average bid amount is ₹974,992.34, indicating participation in a range of medium-value tenders.
- Average Earnest Money Deposit (EMD): An average EMD of ₹81,962.6 demonstrates the financial capacity to participate in tenders requiring substantial bid security.